🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚀 We’re Hiring! Reboot Rx is seeking a Head/VP of Commercialization and Patient Impact to lead the charge in launching accessible and affordable #cancer treatments that improve the standard of care for patients. Help us spread the word. linkedin.com/jobs/view/4118…

💡 Check out our policy memo published by Federation of American Scientists🔬! We propose a dedicated regulatory pathway for non-manufacturers to seek FDA approval of new indications for repurposed generic drugs. Thank you to Arnold Ventures for funding. 👉 fas.org/publication/cl… #DayOne2025

🚀 We are hiring a Manager of Business Operations! This role will support our internal organizational processes and team as we develop affordable cancer treatments. linkedin.com/jobs/view/4126… #cancer #healthcare #patientimpact #operations #nonprofit #startups #hiring #jobs

Today, on #WorldCancerDay, we honor patients, caregivers, and those working to cure cancer. At Reboot Rx, we’re advancing affordable, evidence-based treatments to improve patient outcomes. Together, we can create a future where everyone has access to the care they need.

Thank you to Boston 25 News & Kelly Sullivan for featuring Reboot Rx & Laura Kleiman! The segment highlights our work advancing affordable, evidence-based #cancer treatments and how it could be a game changer. Watch: boston25news.com/news/local/its… DRK Foundation #TheSolutionMayAlreadyExist

We are proud supporters of Reboot Rx, which uses AI technology to fast-track the development of affordable cancer treatments through repurposed generic drugs. Founder and CEO Laura Kleiman was featured in the Boston News: watch the segment to learn more about how Laura and her

Glad to join the Data-Driven #DrugRepurposing panel at the MIT Sloan School of Management Healthcare Conference to discuss how repurposing will reshape the clinical landscape over the next 10 years. And great to catch up with former Reboot Rx team member Gloria Wu! #TheSolutionMayAlreadyExist

Our CEO, Laura Kleiman, spoke on the "Value & Product-Market Fit" panel at HealthTech Build. She shared about achieving real-world adoption of affordable cancer treatments by overcoming barriers and aligning incentives. #Innovation #WomenInScience #TheSolutionMayAlreadyExist

Join our CEO Laura Kleiman at #ASPET2025 for Friday’s keynote on how AI + repurposed generic drugs are unlocking access to cancer care! 📅 April 4 | ⏰ 9–10 AM PDT #PatientImpact #DrugRepurposing #CancerResearch #Innovation #SocialImpact #RebootRx #TheSolutionMayAlreadyExist

#MeetTheTeam - Meet Kathleen Berryman, our new Manager of Business Operations at Reboot Rx! With 15+ years of nonprofit & for-profit business ops experience, we're excited to have her on the team! Learn more: rebootrx.org/berryman. #PatientImpact #TheSolutionMayAlreadyExist

At #TxBiomedGHS, Laura Kleiman joined John Ainslie, Kristi Cooper, Matt Crommett, and moderator Aaron Asel to highlight how philanthropic support can bring affordable, evidence-based cancer care to patients faster. Bold funding makes bold impact! #TheSolutionMayAlreadyExist

Repurposing existing drugs offers a faster, more affordable path to cancer treatments, but no sector can do it alone. We’re grateful to work with partners who share our commitment to helping patients access effective, low-cost therapies. #TheSolutionMayAlreadyExist

Excited to connect with colleagues at #iDR25 next week in Amsterdam! If you’re working on generic #drugrepurposing and think a regulatory approval pathway could help, please reach out. Agenda: remedi4all.org/2025-internati… Reboot Rx REMEDi4ALL Beacon for Rare Diseases #TheSolutionMayAlreadyExist

At #iDR25, our CEO Laura Kleiman joined leaders from Anticancer Fund, Cures Within Reach, King's College London, @AmsterdamUMC, & @LUMC_leiden to discuss new efforts to expand patient access to repurposed generic drugs. #TheSolutionMayAlreadyExist #DrugRepurposing

May is #NationalCancerResearchMonth. ~15% of generics have shown promise for treating new cancer indications, but we need clinical trials to prove what works. Check out the funding opportunity for AI-driven trials from Cures Within Reach & Chan Zuckerberg Initiative! #TheSolutionMayAlreadyExist

Join us on May 29 for a Duke-Margolis workshop on how regulatory and policy solutions can help overcome key challenges in generic drug repurposing. Our team will be presenting alongside other experts. healthpolicy.duke.edu/events/generic… #TheSolutionMayAlreadyExist

At Duke-Margolis, Devon Crittenden presented Reboot Rx’s proposed Labeling-Only Repurposing Pathway. This common-sense extension of the 505(b)(2) pathway would streamline FDA approvals for nonprofits pursuing new uses for generics and expand access. #TheSolutionMayAlreadyExist

This #NationalCancerSurvivorsDay, we honor all living with & beyond cancer. We’re inspired by our advisor Doug Ulman, whose lived cancer experience has driven lasting change with Ulman Foundation, Livestrong, @pelotonia, and ORLI. #TheSolutionMayAlreadyExist #NCSD2025

It's International #MensHealthWeek—a crucial time to talk about cancer awareness. 1 in 5 men will face a cancer diagnosis, and early detection saves lives. Encourage the men in your life to talk to their doctor and stay up to date with testing. #TheSolutionMayAlreadyExist

Another fantastic #PrevConf25 conference with Cancer Research UK, American Cancer Society, & National Cancer Institute! Energizing discussions on repurposing generics for #cancerprevention and early interception. Highlight: connecting with Sir John Burns about the Sir John Burn trial results. #TheSolutionMayAlreadyExist